Autonomous Chest X-ray Oxipit’s ChestLink offers autonomous AI for normal chest X-rays with high sensitivity, presenting a sales angle to radiology departments seeking to reduce reads and improve throughput.

Portfolio Expansion Recent launches of CT Eye and MSK Eye expand beyond chest X-ray into chest CT and musculoskeletal X-ray workflows, signaling cross-sell opportunities to existing NPV and imaging centers transitioning to multi-modality AI.

CE Certification ChestLink is CE Class 2B certified and Oxipit holds ISO 13485 and IEC 62304 credentials, which can ease regulatory and procurement hurdles for hospitals exploring AI adoption.

Strategic Partnerships Partnerships with Unilabs and acquisition by Sectra indicate strong market validation and potential for co-selling, integration partnerships, and larger contract opportunities with enterprise imaging groups.

Growth Journey With revenue in the early range and a growing leadership team, there is a clear opportunity to position Oxipit as a scalable AI radiology solution for mid-market and regional health systems seeking efficiency gains.